AstraZeneca expands US manufacturing footprint to accelerate ambitions in next-generation cell therapy discovery and development

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 6/14/2026

1. ADBE
2. SPCX
3. USO
4. SPY
5. RH
6. NVDA
7. RKLB
8. MSFT
9. CRM
10. CRWV

Go back to AstraZeneca expands US manufacturing footprint to accelerate ambitions in next-generation cell therapy discovery and development

Deutsche Bank Downgrades AstraZeneca (AZN) to Hold

February 8, 2024 5:37 AM EST

Deutsche Bank analyst Emmanuel Papadakis downgraded AstraZeneca (NASDAQ: AZN) from Buy to Hold.

The analyst comments "Q4 is a thoroughly underwhelming end to 2023 with a soft print that missed in most of the places that matter (Enhertu included, again), whilst FY24 guidance is... More